$INCY
INCYTE CORP

2022 Q1 Form 10-Q Financial Statement

#000155837022006808 Filed on May 03, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $733.2M $604.7M
YoY Change 21.25% 6.37%
Cost Of Revenue $42.61M $29.22M
YoY Change 45.84% 6.96%
Gross Profit $690.6M $575.5M
YoY Change 20.0% 6.34%
Gross Profit Margin 94.19% 95.17%
Selling, General & Admin $209.6M $153.8M
YoY Change 36.27% 38.37%
% of Gross Profit 30.35% 26.72%
Research & Development $353.4M $306.9M
YoY Change 15.14% -71.72%
% of Gross Profit 51.17% 53.33%
Depreciation & Amortization $16.44M $13.84M
YoY Change 18.79% 5.65%
% of Gross Profit 2.38% 2.4%
Operating Expenses $563.0M $460.7M
YoY Change 22.2% -61.49%
Operating Profit $116.5M $98.80M
YoY Change 17.96% -114.88%
Interest Expense $680.0K $359.0K
YoY Change 89.42% -40.37%
% of Operating Profit 0.58% 0.36%
Other Income/Expense, Net $1.260M -$1.407M
YoY Change -189.55% -116.24%
Pretax Income $70.54M $69.32M
YoY Change 1.75% -109.85%
Income Tax $32.50M $15.80M
% Of Pretax Income 46.08% 22.79%
Net Earnings $37.99M $53.54M
YoY Change -29.03% -107.43%
Net Earnings / Revenue 5.18% 8.85%
Basic Earnings Per Share $0.17 $0.24
Diluted Earnings Per Share $0.17 $0.24
COMMON SHARES
Basic Shares Outstanding 221.3M 219.8M
Diluted Shares Outstanding 223.0M 221.9M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.544B $1.962B
YoY Change 29.65% 50.65%
Cash & Equivalents $2.257B $1.670B
Short-Term Investments $287.4M $292.4M
Other Short-Term Assets $146.1M $73.50M
YoY Change 98.82% 52.81%
Inventory $35.50M $16.70M
Prepaid Expenses
Receivables $562.3M $397.3M
Other Receivables $0.00 $100.0K
Total Short-Term Assets $3.288B $2.450B
YoY Change 34.21% 42.76%
LONG-TERM ASSETS
Property, Plant & Equipment $729.2M $594.7M
YoY Change 22.63% 45.03%
Goodwill $155.6M $155.6M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $174.7M $202.2M
YoY Change -13.61% 11.71%
Other Assets $31.42M $38.81M
YoY Change -19.04% -37.17%
Total Long-Term Assets $1.766B $1.211B
YoY Change 45.78% 16.91%
TOTAL ASSETS
Total Short-Term Assets $3.288B $2.450B
Total Long-Term Assets $1.766B $1.211B
Total Assets $5.054B $3.661B
YoY Change 38.04% 33.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $152.5M $85.06M
YoY Change 79.34% 39.58%
Accrued Expenses $609.3M $420.9M
YoY Change 44.77% 27.53%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.796M $2.300M
YoY Change 21.57% -88.14%
Total Short-Term Liabilities $886.2M $623.9M
YoY Change 42.04% 23.93%
LONG-TERM LIABILITIES
Long-Term Debt $31.39M $32.20M
YoY Change -2.53% 0.63%
Other Long-Term Liabilities $69.47M $54.46M
YoY Change 27.56% 37.99%
Total Long-Term Liabilities $69.47M $54.46M
YoY Change 27.56% 37.99%
TOTAL LIABILITIES
Total Short-Term Liabilities $886.2M $623.9M
Total Long-Term Liabilities $69.47M $54.46M
Total Liabilities $1.191B $933.6M
YoY Change 27.59% 14.59%
SHAREHOLDERS EQUITY
Retained Earnings -$739.9M -$1.673B
YoY Change -55.77% -22.24%
Common Stock $4.626B $4.421B
YoY Change 4.63% 7.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.863B $2.728B
YoY Change
Total Liabilities & Shareholders Equity $5.054B $3.661B
YoY Change 38.04% 33.03%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $37.99M $53.54M
YoY Change -29.03% -107.43%
Depreciation, Depletion And Amortization $16.44M $13.84M
YoY Change 18.79% 5.65%
Cash From Operating Activities $215.7M $206.1M
YoY Change 4.68% -130.16%
INVESTING ACTIVITIES
Capital Expenditures -$17.01M -$48.10M
YoY Change -64.64% 22.39%
Acquisitions
YoY Change
Other Investing Activities $258.0K -$11.70M
YoY Change -102.21% -83.12%
Cash From Investing Activities -$16.75M -$59.75M
YoY Change -71.97% -44.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 96.00K 12.84M
YoY Change -99.25% 413.61%
NET CHANGE
Cash From Operating Activities 215.7M 206.1M
Cash From Investing Activities -16.75M -59.75M
Cash From Financing Activities 96.00K 12.84M
Net Change In Cash 199.3M 156.8M
YoY Change 27.07% -119.91%
FREE CASH FLOW
Cash From Operating Activities $215.7M $206.1M
Capital Expenditures -$17.01M -$48.10M
Free Cash Flow $232.7M $254.2M
YoY Change -8.44% -139.46%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
221409550
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Excluding Service Cost Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherNonoperatingIncomeExpense
CY2022Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost Credit Excluding Service Cost Statement Of Income Or Comprehensive Income Extensible List
DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherNonoperatingIncomeExpense
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000879169
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
221084433
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-12400
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
INCYTE CORP
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3136539
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1801 Augustine Cut-Off
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Wilmington
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
DE
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19803
CY2022Q1 dei City Area Code
CityAreaCode
302
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
498-6700
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, $.001 par value per share
CY2022Q1 dei Trading Symbol
TradingSymbol
INCY
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 us-gaap Assets Current
AssetsCurrent
3288091000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
3118674000
CY2022Q1 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
1700000
CY2021Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
1720000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
729217000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
723920000
CY2022Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
27392000
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
27548000
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
221505011
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2256759000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2057440000
CY2022Q1 us-gaap Debt Securities Available For Sale Amortized Cost Current
DebtSecuritiesAvailableForSaleAmortizedCostCurrent
291613000
CY2021Q4 us-gaap Debt Securities Available For Sale Amortized Cost Current
DebtSecuritiesAvailableForSaleAmortizedCostCurrent
291871000
CY2022Q1 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2021Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2022Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
287401000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
290752000
CY2022Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
562344000
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
616300000
CY2022Q1 us-gaap Inventory Net
InventoryNet
35457000
CY2021Q4 us-gaap Inventory Net
InventoryNet
27904000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
146130000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
126278000
CY2022Q1 us-gaap Long Term Investments
LongTermInvestments
174681000
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
221266000
CY2022Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
35384000
CY2021Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
29034000
CY2022Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
145371000
CY2021Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
150755000
CY2022Q1 us-gaap Goodwill
Goodwill
155593000
CY2021Q4 us-gaap Goodwill
Goodwill
155593000
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
465369000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
467538000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
31423000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
37304000
CY2022Q1 us-gaap Assets
Assets
5054221000
CY2021Q4 us-gaap Assets
Assets
4933352000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
152547000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
172110000
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
83657000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
108962000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
609290000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
533595000
CY2022Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2796000
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2635000
CY2022Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1535
CY2022Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
37873000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
37006000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
886163000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
854308000
CY2022Q1 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
204127000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
206994000
CY2022Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
31385000
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
31632000
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
69474000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
70414000
CY2022Q1 us-gaap Liabilities
Liabilities
1191149000
CY2021Q4 us-gaap Liabilities
Liabilities
1163348000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
221409550
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
221084433
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
221000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
221000
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4625780000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4567111000
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-23047000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-19454000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-739882000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-777874000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
3863072000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3770004000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5054221000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4933352000
CY2022Q1 us-gaap Revenues
Revenues
733235000
CY2021Q1 us-gaap Revenues
Revenues
604718000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
42614000
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
29220000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
353373000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
306896000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
209584000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
153795000
CY2022Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
6382000
CY2021Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
5526000
CY2022Q1 incy Collaboration Loss Sharing Expense
CollaborationLossSharingExpense
4742000
CY2021Q1 incy Collaboration Loss Sharing Expense
CollaborationLossSharingExpense
10484000
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
616695000
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
505921000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
116540000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
98797000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1260000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1407000
CY2022Q1 us-gaap Interest Expense
InterestExpense
680000
CY2021Q1 us-gaap Interest Expense
InterestExpense
359000
CY2022Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-46585000
CY2021Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-27709000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
70535000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
69322000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32543000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15787000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
37992000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
53535000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
221326000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
219801000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222950000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
221867000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
37992000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
53535000
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-782000
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-5308000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3093000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-32000
CY2022Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-282000
CY2021Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-342000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3593000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4998000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
34399000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
48537000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2611268000
CY2021Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
389512
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
20028000
CY2021Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1357
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
108000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
47903000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4998000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
53535000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
2727844000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3770004000
CY2022Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
323582
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
14237000
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
112000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
44320000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3593000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
37992000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
3863072000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
37992000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
53535000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16438000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13838000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
43841000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
47358000
CY2022Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-2106000
CY2021Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-70000
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2091000
CY2021Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-4622000
CY2022Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-46585000
CY2021Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-27709000
CY2022Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
6382000
CY2021Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
5526000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-53956000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-84637000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
13971000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
10777000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13903000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4406000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-19563000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-13709000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
53787000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2308000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
215741000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
206095000
CY2021Q1 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
8662000
CY2021Q1 us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
1080000
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
17006000
CY2021Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
48083000
CY2021Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
39301000
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
258000
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
35213000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16748000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-59753000
CY2022Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
16398000
CY2021Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
22376000
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2161000
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2348000
CY2022Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
668000
CY2021Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
573000
CY2022Q1 incy Payment Of Contingent Consideration
PaymentOfContingentConsideration
13473000
CY2021Q1 incy Payment Of Contingent Consideration
PaymentOfContingentConsideration
6620000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
96000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12835000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
210000
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2331000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
199299000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
156846000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2059160000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1514765000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2258459000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1671611000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3472000
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
339000
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
15764000
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
21262000
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1618000
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1898000
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
584000
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
68000
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><i style="font-style:italic;">Use of Estimates.</i>  The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</p>
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
733235000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
604718000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2022Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
14717000
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1275000
CY2022Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
37267000
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
39895000
CY2022Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
18857000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
15768000
CY2022Q1 incy Inventory Net Current And Noncurrent
InventoryNetCurrentAndNoncurrent
70841000
CY2021Q4 incy Inventory Net Current And Noncurrent
InventoryNetCurrentAndNoncurrent
56938000
CY2022Q1 us-gaap Inventory Net
InventoryNet
35500000
CY2022Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
35400000
CY2022Q1 incy Inventory Recorded As Research And Development Expense
InventoryRecordedAsResearchAndDevelopmentExpense
69900000
CY2022Q1 incy Period Of Deviation From Average Cost Of Goods Sold
PeriodOfDeviationFromAverageCostOfGoodsSold
P31M
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
915028000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
899640000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
185811000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
175720000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
729217000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
723920000
CY2022Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
171957000
CY2021Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
168412000
CY2022Q1 incy Accrued Clinical Related Costs Current
AccruedClinicalRelatedCostsCurrent
137241000
CY2021Q4 incy Accrued Clinical Related Costs Current
AccruedClinicalRelatedCostsCurrent
109486000
CY2022Q1 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
162997000
CY2021Q4 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
136541000
CY2022Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
37134000
CY2021Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
35750000
CY2022Q1 us-gaap Construction Payable Current
ConstructionPayableCurrent
15763000
CY2021Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
27098000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9904000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10554000
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
74294000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
45754000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
609290000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
533595000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
43800000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
47300000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Method Used
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsMethodUsed
Black-Scholes valuation model
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
3966888
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
84.91
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
4055392
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
84.11
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
10113298
CY2022Q1 incy Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesGranted
1692980
CY2022Q1 incy Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Canceled
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesCanceled
628567
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
9048885
CY2022Q1 incy Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Annualized Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedAnnualizedForfeitureRate
0.05
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32500000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15800000
CY2021 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
-569000000.0
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
408200000
CY2022Q1 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
6300000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
37992000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
53535000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
221326000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
219801000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
37992000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
53535000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
221326000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
219801000
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1624000
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2066000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222950000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
221867000
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2022Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
4900000
CY2021Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
4100000
CY2022Q1 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
2522000
CY2021Q1 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
1955000
CY2022Q1 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
64000
CY2021Q1 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
22000
CY2022Q1 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
1071000
CY2021Q1 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
15000
CY2022Q1 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
194000
CY2021Q1 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
54000
CY2022Q1 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-88000
CY2021Q1 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-288000
CY2022Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
1797000
CY2021Q1 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
2304000
CY2022Q1 us-gaap Defined Benefit Plan Expected Future Employer Contributions Current Fiscal Year
DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear
6400000

Files In Submission

Name View Source Status
0001558370-22-006808-index-headers.html Edgar Link pending
0001558370-22-006808-index.html Edgar Link pending
0001558370-22-006808.txt Edgar Link pending
0001558370-22-006808-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
incy-20220331.xsd Edgar Link pending
incy-20220331x10q.htm Edgar Link pending
incy-20220331x10q_htm.xml Edgar Link completed
incy-20220331xex31d1.htm Edgar Link pending
incy-20220331xex31d2.htm Edgar Link pending
incy-20220331xex32d1.htm Edgar Link pending
incy-20220331xex32d2.htm Edgar Link pending
incy-20220331_cal.xml Edgar Link unprocessable
incy-20220331_def.xml Edgar Link unprocessable
incy-20220331_lab.xml Edgar Link unprocessable
incy-20220331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending